দেশ: আয়ার্লণ্ড
ভাষা: ইংরেজি
সূত্র: HPRA (Health Products Regulatory Authority)
MERTIATIDE
Imaging Equipment Limited
V09CA03
MERTIATIDE
0.2 Milligram
Kit for radiopharmaceutical preparation
Product subject to prescription which may not be renewed (A)
Technetium (99mTc) compounds
Transfer Pending
2013-08-09
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT IELMAG3 0.2 MG KIT FOR RADIOPHARMACEUTICAL PREPARATION Mertiatide (mercaptoacetyltriglycine) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU WILL BE ADMINISTERED THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have any further questions, ask your referring doctor or the specialist physician in Nuclear Medicine who will supervise the procedure. If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your referring doctor or the specialist physician in Nuclear Medicine who has supervised the procedure. IN THIS LEAFLET: 1. What IELMAG3 is and what it is used for 2. Before IELMAG3 is administered 3. How IELMAG3 will be used 4. Possible side effects 5. How IELMAG3 is stored 6. Contents of the pack and other information 1. WHAT IELMAG3 IS AND WHAT IT IS USED FOR This medicine is a radiopharmaceutical product for diagnostic use only. IELMAG3 is used to study the function and structure and blood flow of the kidneys as well as function of the urinary tract, by making an image of these organs. After the medicine is injected, it temporarily collects in certain parts of the body. This radiopharmaceutical substance contains a small amount of radioactivity, which can be detected from outside of the body by using special cameras. Your nuclear medicine doctor will then take an image (scintigraphy) of the concerned organs which can give your doctor valuable information about the about the structure and the func সম্পূর্ণ নথি পড়ুন
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT IELMAG3 0.2 mg kit for radiopharmaceutical preparation 2 QUALITATIVE AND QUANTITATIVE COMPOSITION The kit contains two different vials: (1) and (2). Vial (1) contains 0.2 mg of the mertiatide (mercaptoacetyltriglycine). Vial (2) contains 2.5 mL phosphate buffer solution. For a full list of excipients, see section 6.1. The radionuclide is not part of the kit. The kit contains all non radioactive components required for the reconstitution of technetium-( 99m Tc) mertiatide solution for injection. 3 PHARMACEUTICAL FORM Kit for radiopharmaceutical preparation. Vial 1: white to off-white powder Vial 2: clear, colourless solution 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS This medicinal product is for diagnostic use only. This is indicated for adults. For paediatric population see section 4.2. After radiolabelling with sodium pertechnetate( 99m Tc) solution, the solution of technetium-( 99m Tc) mertiatide, is used for the evaluation of nephrological and urological disorders in particular for the study of function, morphology and perfusion of the kidneys and characterisation of urinary outflow. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults and elderly population_ 40 - 200 MBq, depending on the pathology to be studied and the method to be used. _Population aged less than 18 years_ Although IELMAG3 0.2 mg kit for radiopharmaceutical preparation may be used in paediatric patients, formal studies have not been performed. Clinical experience indicates that, for paediatric use, the activity should be reduced. Because of the variable relationship between the size and body weight of patients, it is sometimes more satisfactory to adjust activities to body surface area. The use in children and adolescents has to b সম্পূর্ণ নথি পড়ুন